The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental ...

Calling consciousness an "entropic engine" points to something psychologically obvious: selfhood costs energy. Maintaining a stable "me" model across time, contexts, and internal contradictions ...

Unless you’ve been living on a desert island with no Wi-Fi, you know that in 2025 marketing was dominated by talk of AI. So instead of more predictions about generative or agentic AI, let’s look at ...

With the popularity of AI coding tools rising among some software developers, their adoption has begun to touch every aspect ...

Abstract: This article presents a flexible and efficient methodology to optimize stack-up for multilayer printed circuit boards (PCBs) with enormous search space and various design constraints. PCB ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Abstract: In high-performance processor design, maintaining Return-Address Stack (RAS) integrity is crucial for efficient instruction flow. Yet, separating multi-level branch predictors from ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

The current set of recursion-based questions is limited and could benefit from additional problems to enhance practice and understanding. Adding more questions will help contributors, students, or ...